Abstract: Techniques are described that determine occurrences of lost write by comparing version identifiers of corresponding replica data blocks and checkpoints of data files that include the data blocks. A method determines lost writes that may have occurred among a first set of data blocks and a second set of data blocks. Each data block in the first set of data blocks corresponds to a respective data block in the second set that is a version of data blocks in the first set. The data blocks in the first set and the second set are associated with version identifiers. The second set of data blocks is associated with a second checkpoint for which any version of a data block in the second set associated a version identifier below the second checkpoint has been acknowledged to a database server as having been written to persistent storage.

Abstract: Methods and apparatus to allocating and/or configuring persistent memory are described. In an embodiment, memory controller logic configures non-volatile memory into a plurality of partitions at least in part based on one or more attributes. One or more volumes (visible to an application or operating system) are formed from one or more of the plurality of partitions. Each of the one or more volumes includes one or more of the plurality of partitions having at least one similar attribute from the one or more attributes. In another embodiment, memory controller logic configures a Non-Volatile Memory (NVM) Dual Inline Memory Module (DIMM) into a persistent region and a volatile region. Other embodiments are also disclosed and claimed.

Abstract: Some embodiments include a method. The method can include identifying consumer product locations of multiple consumer products, determining a consumer health code based on health profile information of a consumer, and determining consumer product information to communicate to the consumer. Determining consumer product information to communicate to the consumer can include identifying a consumer location of the consumer and determining the consumer product information based on at least (i) the consumer health code and (ii) the consumer location relative to at least two of the consumer product locations. The method further can include communicating to the consumer the consumer product information. Other embodiments of related methods and systems are also provided.

Abstract: The present application discloses new taxane analogs, intermediates and methods for producing them. The present application is also directed to pharmaceutical formulations comprising abeo-taxanes and methods of treating cancer with the abeo-taxanes.

Abstract: A system and method for tracking passengers during travel events and generating alerts if rules for those travel events are violated includes readers, which are installed in vehicles and obtain location data from one or more positioning systems. As passengers enter or exit the vehicles, the passengers swipe access cards in the readers. The readers then tag passenger identity information with the obtained location data. This information is then transmitted to a monitoring system, which generates rules for each of the travel event of the passengers. During the travel events, the received location data and time information is analyzed and to determine if any of the vehicles are violating the generated rules. The monitoring system generates alerts if any of the generated rules are violated.

Abstract: A lateral flow assay detects and differentiates between viral and bacterial infections. A combined point of care diagnostic device tests markers for viral infection and markers for bacterial infection, to effectively assist in the rapid differentiation of viral and bacterial infections. In one preferred embodiment, the bacterial marker is CRP. In another preferred embodiment, the viral marker is MxA. In some embodiments, it is unnecessary to lyse the cells in the sample prior to applying it to the device.

Abstract: A process for imparting grease, oil and water repellence to a substrate comprises applying by means of a printing process on at least a portion of the surface of such substrate a composition comprising at least one (per)fluoropolyether derivative. By means of such process it is possible to confer suitable grease, oil and water repellence properties to substrates via selective treatment/coating, by significantly reducing total amount of fluoro-containing additive required for the target properties.

Abstract: The present invention relates to stable pharmaceutical compositions comprising entacapone, levodopa and carbidopa, or pharmaceutically acceptable salts or hydrates thereof. The invention also relates to processes for the preparation of such compositions.

Abstract: The present disclosure is directed towards a method for speech intelligibility. The method may include receiving, at one or more computing devices, a first speech input from a first user and performing voice activity detection upon the first speech input. The method may also include analyzing a spectral tilt associated with the first speech input, wherein analyzing includes computing an impulse response of a linear predictive coding (“LPC”) synthesis filter in a linear pulse code modulation (“PCM”) domain and wherein the one or more computing devices includes an adaptive high pass filter configured to recalculate one or more linear prediction coefficients.

Abstract: A device has a base with a mounting surface with a length and a stack, the stack having a diameter smaller than the length and fastened to the mounting surface. The stack may have a plurality of stack conductive layers in addition to a plurality of insulating layers that separate each of the plurality of stack conductive layers. The stack conductive layers may be separated in a manner that aligns them with corresponding printed circuit board conductive layers when the stack portion of the device is inserted into an aperture in a printed circuit board.

Abstract: Described herein are oral pharmaceutical compositions and their use in testosterone replacement therapy applications.

Abstract: Ethernet fault management systems and methods using programmable Type-Length-Value (TLV) offsets combine software-based Operations, Administration, and Maintenance (OAM) protocol support with hardware-based fault management support to delegate generation and processing of OAM protocol messages to hardware devices with the software-based protocol support used to program hardware based on fixed offsets in the OAM protocol messages. The hardware can be designed to be flexible since the hardware can be agnostic to the logic within the OAM protocol which would reside in the software. The Ethernet fault management systems and methods combine the flexibility of software-based approaches with the speed and efficiency of hardware-based approaches.

Abstract: A system is presented. The system includes a stator component, a rotor component rotating inside the stator component, a plurality of features disposed on the periphery of the stator component or the rotor component, and a processing subsystem for determining at least one of an amount of rotor imbalance and an orientation of the rotor imbalance at least based upon feature-to-feature speed variation of the plurality of features.

Abstract: Techniques for transmitted data through a USB port using a PCIe protocol are described herein. In one example, an apparatus includes a host controller, a root port, a multiplexor coupled to the host controller and the root port and a power delivery module. The power delivery module and the multiplexor can transmit and receive a request via a multimode input/output (I/O) interface and the power delivery module can detect a presence of an external device in response to the external device being coupled to the multimode I/O interface. The power delivery module can also send a first request to the external device to discover a vendor identifier of the external device, send a second request to discover at least one alternate mode supported by the external device, and send a third request to enable data transfer via the protocol.

Abstract: Described herein are oral pharmaceutical compositions and their use in testosterone replacement therapy applications.

Abstract: Techniques for transmitted data through a USB port using a PCIe protocol are described herein. In one example, a method includes detecting a coupling of an apparatus and a PCIe compatible device via a Type-C connector and sending at least one vendor defined message to the PCIe compatible device. The method can also include receiving an alternate mode indicator corresponding to a data transfer via a PCIe protocol and sending an enter mode command to the PCIe compatible device to enable the data transfer between the apparatus and the PCIe compatible device via the PCIe protocol. Furthermore, the method can include transferring data between the apparatus and the PCIe compatible device via the Type-C connector with the PCIe protocol.

Abstract: Exemplary methods, apparatuses, and systems infer a context of a user or device. A computer vision parameter is configured according to the inferred context. Performing a computer vision task, in accordance with the configured computer vision parameter. The computer vision task may by at least one of: a visual mapping of an environment of the device, a visual localization of the device or an object within the environment of the device, or a visual tracking of the device within the environment of the device.

Abstract: Apparatus, systems and methods for adaptively reducing blocking artifacts in block-coded video are disclosed. In one implementation, a system includes processing logic at least capable of deblock filtering at least a portion of a line of video data based, at least in part, on edge information and texture information to generate at least a portion of a line of deblocked video data, and an image data output device responsive to the processing logic.

Abstract: The present invention provides for bioavailable oral dosage forms containing esters of 17-hydroxyprogesterone as well as related methods. The oral dosage forms can be formulated for pregnancy support and can include a therapeutically effective amount of an ester of 17-hydroxyprogesterone and a pharmaceutically acceptable carrier. In another embodiment, a pharmaceutically acceptable oral dosage form for pregnancy support is provided. The pharmaceutically acceptable oral dosage can include a therapeutically effective amount of an ester of 17-hydroxyprogesterone and a pharmaceutically acceptable carrier. The oral dosage form can, when measured using a USP Type-II dissolution apparatus in 900 mL of deionized water with 0.5 (w/v) of sodium lauryl sulfate at 50 RPM at 37° C., release at least 20 wt % of the dose of the ester of 17-hydroxyprogesterone after 60 minutes, or in the alternative release at least 20 wt % more after 60 minutes than an equivalently dosed oral dosage form without the carrier.

Abstract: Embodiments of the present invention include systems and methods for detecting and correcting mismatches between a flow's size and the path maximum transmission unit (PMTU) size. In embodiments, a controller is notified of a new flow's size and compares that to the route path's MTU size. If the controller recognizes a mismatch, it informs an information handling device, such as the first-hop router, to notify the sender of the correct path MTU size—thereby effectively and efficiency notifying the sender to correct the MTU size for that flow.